glp-1 news november 2025 Patients Face New Barriers for GLP-1 Drugs GLP-1 Agonists Weight Loss Drugs

LEADER Trial Investigators

Practice Point 4.3.2: To minimize gastrointestinal side effects, start with a low dose of GLP-1 RA, and titrate up slowly.

In turn, this will inform doctors preferences for certain therapies, even brands, to treat specific patient profiles and thus shape the competitive dynamics in the AOM market

Intense and Sustained Alcohol Consumption Associated With Acute Pancreatitis Warrants Early Intervention

Because calorie intake ultimately drives changes in body composition, even modest appetite modulation could influence weight trends

This results in coordinated metabolic improvements via tissue-specific activation of signalling pathways that improve glucose homeostasis, decrease inflammation, and help to improve overall cardiovascular and metabolic health